Is Early Reimplantation of the Duodenal-Jejunal Bypass Liner Viable?

被引：6
|
作者：
Leventi, Eleni [1 ,2 ]
Guenthert, Sarah J. [1 ,2 ]
Stier, Christine [3 ]
Staikov, Plamen [2 ,4 ]
Stein, Juergen [1 ,2 ]
Farrag, Karima [1 ,2 ]
机构：
[1] DGD Clin Sachsenhausen, Dept Gastroenterol Clin Nutr, Schulstr 31, Frankfurt, Germany
[2] DGD Clin Sachsenhausen, Obes Ctr, Frankfurt, Germany
[3] Univ Hosp, Dept Gen Visceral Cardiovasc & Pediat Surg, Wurzburg, Germany
[4] DGD Clin Sachsenhausen, Dept Gen & Bariatr Surg, Frankfurt, Germany
来源：
OBESITY SURGERY | 2019年 / 29卷 / 05期
关键词：
Obesity; Type; 2; diabetes; Duodenal-jejunal bypass liner; Weight loss; Glycaemic control; Obesity surgery; GASTRIC BYPASS; OBESITY;
D O I：
10.1007/s11695-019-03758-y
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The endoscopically implanted duodenal-jejunal bypass liner (DJBL) is an impermeable fluoropolymer device which prevents food making contact with the proximal intestine, thus inducing weight loss and improvement of type 2 diabetes mellitus (T2DM). However, weight and HbA1c levels generally increase post explantation. This study investigated the safety and feasibility of early DJBL reimplantation in five patients with obesity whose glucose levels had relapsed post explantation, examining the effect of reimplantation on weight loss, BMI and T2DM management. All DJBL implantation and explantation procedures were performed without complications. Despite reduction of T2DM medications, reduction in body weight and HbA1c levels resumed after reimplantation. In conclusion, early reimplantation of DJBL appears feasible, safe and effective.
引用
收藏
页码：1690 / 1693
页数：4
相关论文
共 50 条
  • [31] Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity
    Escalona, Alex
    Yanez, Ricardo
    Pimentel, Fernando
    Galvao, Manoel
    Ramos, Almino Cardoso
    Turiel, Dannae
    Boza, Camilo
    Awruch, Diego
    Gersin, Keith
    Ibanez, Luis
    SURGERY FOR OBESITY AND RELATED DISEASES, 2010, 6 (02) : 126 - 131
  • [32] SAFETY PROFILE OF THE DUODENAL-JEJUNAL BYPASS LINER (ENDOBARRIER): A MULTICENTRE RANDOMISED CONTROL TRIAL
    Ruban, Aruchuna
    Glaysher, Michael
    Miras, Alexander
    Prechtl, Christina
    Goldstone, Anthony
    Aldhwayan, Madhawi
    Chhina, Navpreet
    Al-Najim, Werd
    Ashrafian, Hutan
    Byrne, James
    Teare, Julian
    GUT, 2021, 70 : A170 - A170
  • [33] EFFICACY AND SAFETY OF THE DUODENAL-JEJUNAL BYPASS LINER: A PROSPECTIVE COHORT STUDY OF 200 PATIENTS
    Betzel, Bark
    Homan, Jens
    Schijns, Wendy
    Deden, Laura
    van Rens, Michiel
    Aarts, Edo
    Janssen, Ignace
    Wahab, Peter
    Groenen, Marcel
    Berends, Frits
    OBESITY SURGERY, 2015, 25 : S55 - S55
  • [34] Impact of duodenal-jejunal bypass liner on non-alcoholic fatty liver disease
    Karlas, T.
    Feisthammel, J.
    Schuetz, T.
    Blueher, M.
    Lichtinghagen, R.
    Keim, V.
    Hoffmeister, A.
    Wiegand, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S829 - S829
  • [35] The feasibility of delivering a duodenal-jejunal bypass liner (endobarrier) endoscopically with patients under conscious sedation
    Koehestanie, Parviez
    Betzel, Bark
    Dogan, Kemal
    Berends, Frits
    Janssen, Ignace
    Aarts, Edo
    Groenen, Marcel
    Wahab, Peter
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2014, 28 (01): : 325 - 330
  • [36] Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes
    Levine, Andy
    Ramos, Almino
    Escalona, Alex
    Rodriguez, Leonardo
    Greve, Jan Willem
    Janssen, Ignace
    Rothstein, Richard
    Nepomnayshy, Dmitry
    Gersin, Keith S.
    Melanson, David
    Lamport, Ronald
    Fishman, Ezra
    Malomo, Kenneth
    Kaplan, Lee M.
    Galvao Neto, Manoel
    SURGERY FOR OBESITY AND RELATED DISEASES, 2009, 5 (03) : 371 - 374
  • [37] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitus in Morbidly Obese Patients
    Rodrigo Muñoz
    Alex Escalona
    Current Cardiology Reports, 2014, 16
  • [38] Benefits and Risks in 1,101 Duodenal-Jejunal Bypass Liner (DJBL) Treated Patients
    Ryder, Robert E. J.
    Lopez-Gonzalez, Ruth
    Lazzara, Claudio
    Pujol-Gebelli, Jordi
    Stein, Jurgen
    Battelino, Tadej
    Teare, Julian P.
    Ruban, Aruchuna
    Haluzik, Martin
    Munro, Lynne
    Frydenberg, Harry
    Mcmaster, Jessica J.
    Fishman, Sigal
    Stengel, Rainer
    Cohen, Ricardo V.
    Byrne, James P.
    De Jonge, Charlotte
    Greve, Jan Willem
    Mason, John C.
    Bessell, Justin R.
    Kow, Lilian
    Sourij, Harald
    Pferschy, Peter N., Jr.
    Drummond, Russell
    Mcgowan, Barbara
    Amiel, Stephanie A.
    Yadagiri, Mahender
    Sen Gupta, Piya
    Laubner, Katharina
    Seufert, Jochen
    DIABETES, 2024, 73
  • [39] Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study
    Betzel, Bark
    Homan, Jens
    Aarts, Edo O.
    Janssen, Ignace M. C.
    de Boer, Hans
    Wahab, Peter J.
    Groenen, Marcel J. M.
    Berends, Frits J.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (07): : 2881 - 2891
  • [40] Maintenance of efficacy after duodenal-jejunal bypass liner explantation in the first NHS EndoBarrier service
    Ryder, Robert E. J.
    Yadagiri, Mahi
    Irwin, Susan P.
    Burbridge, Wyn
    Gandhi, Hardeep
    Allden, Rachael A.
    Bleasdale, John P.
    Fogden, Edward N.
    Anderson, Mark R.
    Sen Gupta, Piya
    BRITISH JOURNAL OF DIABETES, 2018, 18 (01): : 14 - 17
12345